Rapid Micro Biosystems Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Rapid Micro Biosystems, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Revenue & Gross Profit
Revenue28.0522.5217.1323.2316.08
Cost of Revenue28.1628.0025.671.6224.15
Gross Profit-0.11-5.49-8.5421.62-8.07
Operating Expenses
Research & Development14.6012.8212.879.786.53
Selling, General & Administrative35.2138.2641.8129.7115.94
Operating Expenses49.8151.0854.6865.6722.47
Operating Income-49.92-56.56-63.22-47.23-30.54
Other Income/Expense
Interest Income3.164.211.780.000.00
Interest Expense0.000.000.00-2.61-3.45
Other Income/Expense-0.11-0.080.0625.21-0.05
Income
Income Before Tax-46.87-52.44-61.38-70.26-36.94
Income Tax Expense0.020.03-0.586.010.13
Net Income-46.89-52.47-60.81-73.52-37.08
Net Income - Continuous Operations-46.89-52.47-60.81-73.520.00
Net Income - Discontinued Operations0.000.000.000.000.00
EBITDA-46.96-53.46-60.38-66.12-29.03
EBIT-49.92-56.56-63.22-67.65-30.54
Depreciation & Amortization2.963.112.841.531.51
Earnings Per Share
Basic EPS-1.00-1.00-1.00-4.00-126.00
Diluted EPS-1.00-1.00-1.00-4.00-126.00
Basic Shares Outstanding43.5843.0242.4519.780.36
Diluted Shares Outstanding43.5843.0242.4519.780.36